Brellium Raises $23M for AI-Driven Healthcare Billing Compliance

In a significant move to bolster financial integrity within the healthcare sector, AI-powered compliance specialist Brellium has successfully closed a $23 million funding round. This capital infusion, spearheaded by prominent venture firms Left Lane Capital and First Round Capital, with additional backing from Digital Health Venture Partners, will fuel the expansion of Brellium's innovative solutions designed to preemptively identify and rectify medical billing inaccuracies and documentation gaps.

The healthcare industry grapples with substantial financial leakage stemming from billing errors and compliance oversights, often leading to denied claims and costly audits. Brellium's proprietary AI system, CortexLM, directly addresses this pervasive challenge. By meticulously scrutinizing patient records and clinical notes, the platform flags potential discrepancies and compliance risks *before* claims are submitted to insurers. This proactive approach aims to safeguard providers from significant revenue loss and regulatory penalties, a critical need in an era of heightened payer scrutiny.

The market for revenue cycle management and healthcare compliance technology is substantial, with providers increasingly turning to advanced analytics to navigate complex billing regulations and ensure accurate reimbursement. Brellium's technology offers a compelling alternative to traditional, often manual, review processes that typically sample only a small fraction of patient data. CortexLM, conversely, promises comprehensive, automated oversight across an entire patient population, a capability that can translate into billions in protected revenue, as indicated by the company's reported success in auditing over 22 million patient visits and safeguarding nearly $2 billion.

Founded in 2021, Brellium's mission is to harmonize the often adversarial relationship between providers and payers regarding fraud, waste, and abuse. As stated by CEO Zach Rosen, the goal is to establish a unified standard where providers can confidently demonstrate the accuracy of care delivered from the outset. The company's commitment is further underscored by a unique guarantee: Brellium will cover repayment costs for qualifying issues missed by its software, a bold move aimed at building trust and demonstrating confidence in its AI's efficacy. This strategy is particularly relevant given the increasing complexity of value-based care models and evolving payer requirements.

Brellium's impact is already being felt by industry players. Mental healthcare provider Headspace, for instance, reported a dramatic increase in documentation compliance, moving from a manual review of approximately 2% of therapy notes to 100% automated review with Brellium's system, achieving 99.2% compliance with documentation standards. This case highlights the tangible benefits of AI in enhancing operational efficiency and clinical quality assurance. The company also serves established organizations such as Gentiva, Maxim Healthcare, and Rula, demonstrating broad applicability across different healthcare service models.

With this new funding, Brellium intends to broaden its technological reach into specialized medical fields like cardiology, pain management, and primary care, where documentation and billing intricacies are particularly demanding. This strategic expansion targets areas with high potential for both revenue optimization and compliance risk. The company's prior Series A round in April 2025, also supported by First Round Capital and Left Lane Capital, provided initial momentum, setting the stage for this larger Series B investment. Brellium's success underscores the growing investor confidence in AI solutions that address critical operational pain points in the healthcare ecosystem.